Back
Recursion Pharmaceuticals Stock Price Chart
Buy
72
RXRX
Recursion Pharmaceuticals
Last Price:
7.09
Seasonality Move:
18.05%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.14 | Buy |
| 20-day SMA: | 6.59 | Buy |
| 50-day SMA: | 6.58 | Buy |
| 200-day SMA: | 8.25 | Sell |
| 8-day EMA: | 6.36 | Buy |
| 20-day EMA: | 6.46 | Buy |
| 50-day EMA: | 6.63 | Buy |
| 200-day EMA: | 7.62 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 57.65 | Buy |
| Chaikin Money Flow: | 10857249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.06 - 7.14) | Buy |
| Bollinger Bands (100): | (6.19 - 7.59) | Buy |
Recursion Pharmaceuticals Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 7.07 while RXRX 8-day simple moving average is 6.14, which is a Buy signal.
- The stock price of RXRX is 7.07 while Recursion Pharmaceuticals 20-day SMA is 6.59, which makes it a Buy.
- Recursion Pharmaceuticals 50-day simple moving average is 6.58 while RXRX share price is 7.07, making it a Buy technically.
- RXRX stock price is 7.07 and Recursion Pharmaceuticals 200-day simple moving average is 8.25, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Buy
72
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a Buy
The current Recursion Pharmaceuticals [RXRX] share price is $7.07. The Score for RXRX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
2.03B
Price in USD:
7.07
Share Volume:
13.36M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
15.74
52-Week Low:
5.60
Buy
72
Recursion Pharmaceuticals (RXRX)
is a Buy
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?
The Recursion Pharmaceuticals stock price is 7.07 USD today. -
Will RXRX stock go up or go down?
Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Recursion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is not overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 7.07 while RXRX 8-day exponential moving average is 6.36, which is a Buy signal.
- The stock price of RXRX is 7.07 while Recursion Pharmaceuticals 20-day EMA is 6.46, which makes it a Buy.
- Recursion Pharmaceuticals 50-day exponential moving average is 6.63 while RXRX share price is 7.07, making it a Buy technically.
- RXRX stock price is 7.07 and Recursion Pharmaceuticals 200-day simple moving average is 7.62, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
- RXRX Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Recursion Pharmaceuticals is a Sell
- Recursion Pharmaceuticals Relative Strength Index (RSI) is 57.65, which suggest Recursion Pharmaceuticals is overbought
- The Bollinger Bands (25) for Recursion Pharmaceuticals is (6.06 - 7.14), which suggest Recursion Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Recursion Pharmaceuticals is (6.19 - 7.59), which suggest Recursion Pharmaceuticals is a Buy
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.